Warning:
Zofran® Injuries

Pregnant Mothers at Risk for Birth Defects

Click here to take the first step

Zofran® is manufactured by GlaxoSmithKline and was approved by the FDA in 1991 for treating nausea and vomiting in patients after undergoing chemotherapy or surgery. Zofran® is also prescribed for unapproved uses such as treating morning sickness in pregnant women. Zofran®, also known by its generic name Ondansetron, works by blocking serotonin, a neurotransmitter that controls areas of the brain that trigger nausea and vomiting.

Was your child born with a serious birth defect?

Various studies have shown a correlation between Zofran® taken during pregnancy and birth defects. A 2011 study by the Slone Epidemiology Center and the Centers for Disease Control and Prevention revealed an increased risk of cleft palate defects in children whose mothers took Zofran® during the first trimester.

Birth defects related to Zofran® include:

  • Heart defects

  • Kidney defects

  • Cleft lip

  • Cleft palate

You and your child may be entitled to financial compensation

If your child was born with a birth defect and you took Zofran® while pregnant, your family may be entitled to financial compensation for:

  • Medical bills

  • Medical treatment

  • Lost wages

  • Family needs

  • Other expenses

Contact us today for a free case evaluation.

Zofran® is manufactured in various forms:

  • Zofran® Tablets (ondansetron hydrochloride)

  • Zofran ODT® Orally Disintegrating Tablets (Ondansetron)

  • Zofran® Oral Solution (Ondansetron Hydrochloride)

 

Do not stop taking medication without speaking with your health care professional.

Know Your Rights

For over 75 combined years, our legal team has successfully helped thousands of victims and families. If you or a loved one used Zofran® during pregnancy and had a child born with a serious birth defect, call us at 800-818-4301 or fill out the form for a free consultation.

Free Legal Consultation

  • This field is for validation purposes and should be left unchanged.